Labiotech.eu

News and Trends 19 Jul 2018

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Kite will support Gadeta in the development of a new type of CAR-T therapy that could be more effective in solid tumors. Approved just last year, CAR-T cell therapy is offering hope to patients with severe forms of blood cancer. The developer of one of only two CAR-T therapies currently in the market, Kite, has […]

July 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 18 Jul 2018

Lab-Grown Meat Will Be on the Market in 2021

Dutch startup Mosa Meat has raised €7.5M in a Series A round, which will support the development of a first lab-grown meat product that is expected to make it to market by 2021. Mosa Meat is a Dutch startup co-founded by Mark Post, the scientist behind the world’s first lab-grown burger. After an early investment […]

July 18, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Jul 2018

Gene Therapy Could Prevent Deadly Brain Disease

An international research team used gene therapy to prevent Gaucher disease, a potentially deadly neurodegenerative condition, in mice. The approach could eventually be used to treat human diseases in the womb. A research team from the UK and Singapore showed that a neurodegenerative condition called Gaucher disease, which can be fatal, can be prevented in […]

July 17, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 16 Jul 2018

CRISPR-Cas9 Shown to Cause Previously Unseen DNA Damage

Researchers at the Wellcome Trust Sanger Institute in the UK have found that gene editing with CRISPR-Cas9 can cause significantly more off-target damage to the DNA than previously thought. Published today in Nature Biotechnology, the study is the first to look at unexpected DNA changes caused by CRISPR across large regions of the genome. […]

July 16, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Sickle Cell Disease Modus Therapeutics Cover

News and Trends 16 Jul 2018

Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment

Modus Therapeutics closed SEK 140M (€13.5M) in Series A financing to complete a Phase II study testing its sickle cell disease drug and to prepare for further clinical trials. The financing round was led by HealthCap, a European venture capital firm focused on life science investments, which will contribute SEK 60M (€5.8M). The remaining funds […]

July 16, 2018 - 3 minutesmins - By Alexander Burik

Flow State Francis Crick Institute Alex May

More News! 14 Jul 2018

An Artist’s Insight into the Day-to-Day Life at the Francis Crick Institute

A new interactive art installation at the Francis Crick Institute in London lets visitors peek into what life at the famous research institute is like. “The Francis Crick Institute is this incredible, huge, imposing building of which the public can see very little inside,” Alex May, a British digital artist, told me during an interview. His […]

July 14, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Jul 2018

French Biotech Raises €12.5M for Antibiotic Booster Drugs

French-biotech Antabio closed €12.5M at series A to fund its pipeline of antibiotic booster drugs that should help in the global fight against antimicrobial resistance. After raising €7.3M last year, Antabio extended its Series A financing round with €5.2M of additional funding raised from private investors. The French biotech will use the funding to continue […]

July 13, 2018 - 2 minutesmins - By Alexander Burik

In Depth 12 Jul 2018

How Plant Biotechnology Can Give Us Better Food and Medicines

From super crops to better medicines, biotechnology from plants could make a big difference in our lives. Here’s how. What have plants ever done for us? Well, a colossal amount of things. Throughout human history, they have fed us, made medicinal compounds, given us clothes, produced oxygen and much more. However, what if there were […]

July 12, 2018 - 4 minutesmins - By Jonathan Smith

News and Trends 12 Jul 2018

Collaboration Worth Over €1Bn Could Give Rise to New Cancer Immunotherapies

Genmab is partnering with the German company Immatics to develop immunotherapies directed against three cancer targets. Genmab has offered Immatics, based in Tuebingen, Germany, an upfront payment of $54M (€46M) in addition to milestone payments worth up to $550M (€470M) for each product. Genmab has a market cap of €60Bn ($70Bn). The funding will be […]

July 12, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 11 Jul 2018

Radioactive Nanoparticle Could Improve Cancer Diagnoses

Isotopia Molecular Imaging, an Israeli company, is developing a radioactive marker made of gold nanoparticles to detect cancer more accurately than with current diagnostic tools. PET and CT scans are two types of X-ray tests that use small quantities of radioactive materials, called contrast agents, to help visualize and assess organ and tissue function. These […]

July 11, 2018 - 2 minutesmins - By Alexander Burik

Expert Advice 11 Jul 2018

How Successful Life Science Businesses Generate Their Leads with “White Paper Marketing”

The life science sector is full of ambitious professionals who are both overwhelmingly busy and voracious learners. This presents a problem and an opportunity. If you can employ educational marketing to your market, leaving your readers significantly more informed on an important issue than before they found you, you can position yourself as a […]

July 11, 2018 - 9 minutesmins - By James Mathison

Retinitis pigmentosa gene therapy Horama

News and Trends 11 Jul 2018

Gene Therapy for Retinitis Pigmentosa Tested in Humans for the First Time

French biotech Horama has treated the first patients with a gene therapy for retinitis pigmentosa that could prevent the progressive loss of vision caused by this genetic condition. A Phase I/II trial with Horama’s gene therapy for retinitis pigmentosa is running at the Nantes University Hospital. The therapy is aimed at fixing genetic defects in a […]

July 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Lab-Grown Meat Will Be on the Market in 2021

Gene Therapy Could Prevent Deadly Brain Disease

CRISPR-Cas9 Shown to Cause Previously Unseen DNA Damage

Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment

An Artist’s Insight into the Day-to-Day Life at the Francis Crick Institute

French Biotech Raises €12.5M for Antibiotic Booster Drugs

How Plant Biotechnology Can Give Us Better Food and Medicines

Collaboration Worth Over €1Bn Could Give Rise to New Cancer Immunotherapies

Radioactive Nanoparticle Could Improve Cancer Diagnoses

How Successful Life Science Businesses Generate Their Leads with “White Paper Marketing”

Gene Therapy for Retinitis Pigmentosa Tested in Humans for the First Time

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!